These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 20573807)

  • 1. Increased behavioural problems associated with corticosteroid use in children with nephrotic syndrome: a Southeast Asian perspective.
    Mahmud MN; Othman A; Ilias MI
    Singapore Med J; 2023 Sep; 64(9):557-562. PubMed ID: 34600452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolites play an underappreciated role in development.
    Juliano CE
    Proc Natl Acad Sci U S A; 2024 Jul; 121(29):e2410810121. PubMed ID: 38976745
    [No Abstract]   [Full Text] [Related]  

  • 3. Corticosteroid therapy for nephrotic syndrome in children.
    Hahn D; Samuel SM; Willis NS; Craig JC; Hodson EM
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD001533. PubMed ID: 39171624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis.
    Ji B; Liu J; Yin Y; Xu H; Shen Q; Yu J
    Cell Death Dis; 2023 Sep; 14(9):601. PubMed ID: 37689694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid therapy for nephrotic syndrome in children.
    Hahn D; Samuel SM; Willis NS; Craig JC; Hobson EM
    Cochrane Database Syst Rev; 2020 Aug; 2020(8):CD001533. PubMed ID: 35659203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of behavioral abnormalities following corticosteroid therapy in children with initial episode of idiopathic nephrotic syndrome: a prospective longitudinal observation.
    Singh P; Mishra OP; Upadhyay SK; Prasad R; Singh A; Abhinay A; Mishra A; Schaefer F
    J Bras Nefrol; 2022; 44(1):58-67. PubMed ID: 34590671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166-001, 6/2020.
    Ehren R; Benz MR; Brinkkötter PT; Dötsch J; Eberl WR; Gellermann J; Hoyer PF; Jordans I; Kamrath C; Kemper MJ; Latta K; Müller D; Oh J; Tönshoff B; Weber S; Weber LT;
    Pediatr Nephrol; 2021 Oct; 36(10):2971-2985. PubMed ID: 34091756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of blended training on the quality of life of children with nephrotic syndrome.
    Khanjari S; Jahanian S; Haghani H
    J Family Med Prim Care; 2018; 7(5):921-926. PubMed ID: 30598934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural abnormalities in children with new-onset nephrotic syndrome receiving corticosteroid therapy: results of a prospective longitudinal study.
    Upadhyay A; Mishra OP; Prasad R; Upadhyay SK; Schaefer F
    Pediatr Nephrol; 2016 Feb; 31(2):233-8. PubMed ID: 26416481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroid therapy for nephrotic syndrome in children.
    Hahn D; Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD001533. PubMed ID: 25785660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of rituximab on height and weight in children with refractory steroid-dependent nephrotic syndrome.
    Sato M; Ito S; Ogura M; Kamei K
    Pediatr Nephrol; 2014 Aug; 29(8):1373-9. PubMed ID: 24599443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of pediatric nephrotic syndrome on families.
    Mitra S; Banerjee S
    Pediatr Nephrol; 2011 Aug; 26(8):1235-40. PubMed ID: 21626223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural abnormalities in children with nephrotic syndrome--an underappreciated complication of a standard treatment?
    Neuhaus TJ; Langlois V; Licht C
    Nephrol Dial Transplant; 2010 Aug; 25(8):2397-9. PubMed ID: 20573807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life and psychosocial adjustment in steroid-sensitive nephrotic syndrome.
    Rüth EM; Landolt MA; Neuhaus TJ; Kemper MJ
    J Pediatr; 2004 Dec; 145(6):778-83. PubMed ID: 15580200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family structure and the course of steroid-sensitive nephrotic syndrome.
    Soliday E; Lande MB
    Pediatr Nephrol; 2002 Jan; 17(1):41-4. PubMed ID: 11793133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural abnormalities in children with nephrotic syndrome.
    Mishra OP; Basu B; Upadhyay SK; Prasad R; Schaefer F
    Nephrol Dial Transplant; 2010 Aug; 25(8):2537-41. PubMed ID: 20200003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotic syndrome in children: should we always use steroids for the initial therapy?
    Feber J; Filler G
    Przegl Lek; 2006; 63 Suppl 3():12-4. PubMed ID: 16898477
    [No Abstract]   [Full Text] [Related]  

  • 18. An updated view of the pathogenesis of steroid-sensitive nephrotic syndrome.
    Horinouchi T; Nozu K; Iijima K
    Pediatr Nephrol; 2022 Sep; 37(9):1957-1965. PubMed ID: 35006356
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.